Behind the satisfying hum of scientific progress, we hear the drumbeat of scientists pushing and shoving. Concerns surface constantly about research integrity, reproducibility and pressure to publish. We need to draw on the history of science and kindle the benefits of three contemplative but immensely practical ideals: reticence, intimacy and innocence.
To be reticent is to reflect on the significance of our work. Pausing can make for better science. Describing the 16-year delay in publishing his book on insectivorous plants, Darwin wrote that "…a man after a long interval can criticize his own work, almost as well as if it were that of another person". The advice remains good today: consider the alarms over humangenome editing.
The precept of intimacy lifts our research beyond the collection of measurements and data. 
Contentious therapy and patients' voices
We wish to clarify two points raised by Eric Topol in his review of our book Everybody Wants to Go to Heaven but Nobody Wants to Die (Nature 572, 308-309; 2019) .
First, mitochondrialreplacement therapy is still banned by the US Food and Drug Administration, and we say nothing to the contrary. In the book, we note that "in 2016, committees in both the United States and the United Kingdom gave cautious green lights for mitochondrial replacement therapy" -not that any US regulatory agency had done so. The reports we cite were produced by the US National Academies and the Nuffield Council on Bioethics
Identifying fossils from protein clues
You claim that the identification of a 160,000-year-old Denisovan jawbone from its proteins alone is a first for palaeoproteomics (Nature 570, 433-436; 2019 
